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Background/aim: Our aim was to investigate the association of kinesiophobia with pain, quality of life, clinical measures, and depression
in patients with ankylosing spondylitis (AS).
Materials and methods: Patients with AS (n: 163) were enrolled in the study. Kinesiophobia was evaluated with the Tampa Scale of
Kinesiophobia (TSK), pain with a visual analog scale (VAS), mobility with Bath Ankylosing Spondylitis Metrology Index (BASMI),
disease activity with the Bath AS Disease Activity Index (BASDAI), functional status with the Bath AS Functional Index (BASFI),
depression level with Beck’s Depression Inventory (BDI), and quality of life with the AS Quality of Life Questionnaire (ASQoL). Besides
correlation analysis, outcome measures were compared between patients with (TSK ≥ 37) and without (TSK < 37) kinesiophobia.
Results: Kinesiophobia was found to be common with a percentage of 66.6%. TSK scores were correlated with VAS, BASFI, ASQoL,
and BDI scores (r = 0.259, r = 0.294, r = 0.392, and r = 0.398, respectively; P < 0.05 for each). There were no correlations between TSK
and the BASDAI and BASMI scores (r = 0.142, r = 0.198, respectively; P > 0.05). Patients with kinesiophobia had more pain and poorer
BASFI, ASQoL, and BDI scores than patients without kinesiophobia (P < 0.05).
Conclusion: Our study is the first study that investigated the relationship between kinesiophobia and other clinical measures in AS
patients. Pain and psychological status have an impact on fear of movement and thus functional status and quality of life.
Key words: Ankylosing spondylitis, quality of life, kinesiophobia, functional status

1. Introduction
Ankylosing spondylitis (AS) is an inflammatory disorder
of the spine that affects skeletal and extraskeletal structures
(1). It is characterized by pain and stiffness of the back
and sacroiliac joints. The burden of illness in AS results
from the pain, reduced spinal mobility and function,
and impaired well-being (2). The aims of treatment in
AS are reduction of pain and stiffness and prevention
of structural deformities and long-term complications,
thereby improving the quality of life (3,4).
Kinesiophobia is defined as an excessive, irrational,
and debilitating fear of physical movement and activity
resulting from a feeling of vulnerability to painful injury
or reinjury (5). The role of the fear of movement in
musculoskeletal pain disorders was examined in studies of
acute and chronic low back pain syndrome. Participation
of patients and thus the continuity of treatment is
important in exercise applications recommended for the
* Correspondence: zeyneptuna6@yahoo.com
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treatment of such chronic diseases. In studies conducted
on various diseases, the negative impacts of kinesiophobia
on rehabilitation processes involving exercise programs,
and consequently its importance in the clinical course,
were reported (6,7).
The most appropriate treatment of AS to increase
and maintain long-term quality of life occurs with
the combinational use of pharmacological and
nonpharmacological
treatments.
Assessment
of
SpondyloArthiritis and the European League Against
Rheumatism strongly noted the importance of
physiotherapy applications in addition to regular exercise
and patient education in all steps of the treatment scheme
(4). In patients with AS, in order to achieve success and
continuity in treatment, it is important that clinicians be
informed about the presence of kinesiophobia and the
factors that increase kinesiophobia, which have not been
investigated to date.
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The aim of this study is to determine the level of
kinesiophobia in patients with AS and to analyze the
correlation between kinesiophobia and quality of life,
functional status, disease activity, pain, and depression.
2. Materials and methods
The protocol of this study was approved by the Gazi
University Clinical Research Ethics Committee. All
participants gave their informed consent prior to the study.
2.1. Participants
The study included patients that were being followed at
the Gazi University Faculty of Medicine, Department
of Rheumatology, and who were diagnosed with AS
based on the modified New York criteria (8). All of
the participants were included in the study by the same
rheumatologist, confirming that they received the same
medical protocol. None of the participants had received
any exercise training before. The study group consisted
of both female and male patients in the age range of
18–65 years. Accompanying systemic diseases (other
rheumatologic diseases, hypertension, diabetes, thyroid
issues, etc.) were investigated, and previous surgeries and
illnesses were recorded. Patients who had musculoskeletal
surgery in the last 12 months or impaired mobility due to
a neurological or vestibular system disorder were excluded
from the study. In addition, patients who were illiterate
and would be unable to answer survey questions correctly
were excluded from the study.
2.2. Assessment parameters
Initially, the age, height, weight, and sex of participants
were recorded and their disease duration, occupation,
tobacco and alcohol consumption, level of education,
personal background, and family histories were questioned.
Consecutive patients who were eligible to participate in
the study according to the inclusion and exclusion criteria
were evaluated. The evaluation consisted of assessment of
pain and mobility and surveys that assessed the patients’
kinesiophobia, disease activity, functionality, quality of
life, and psychological conditions.
2.2.1. Pain
Pain severity was measured with a visual analog scale
(VAS). It consisted of a 100-mm line anchored by ‘No Pain’
written at one end and ‘Worst Imaginable Pain’ written at
the opposite end. The distance in millimeters from the ‘No
Pain’ end to the location of the mark gave a measurement
of the pain.
2.2.2. Mobility
Tragus to wall distance, modified Schober’s test,
thoracolumbar lateral flexion, cervical rotation,
intermalleolar distance, and finger to floor distance as
found in the Bath Ankylosing Spondylitis Metrology Index
(BASMI) were used in the assessment of mobility (9).

2.2.3. Functional level
The Turkish version of the Bath Ankylosing Spondylitis
Functional Index (BASFI) was used to define and monitor
physical functioning. The BASFI comprises ten tasks that
assess the degree of difficulty of each task performed. In
summary, tasks 1–10 assess putting on socks, bending
forward to pick up a pen, reaching a high shelf, getting up
from an armless chair, getting up from the floor from lying
supine, standing unsupported, climbing steps without
a handrail, looking over the shoulders, performing
physically demanding activities, and doing a full day’s
activities. The total BASFI score is calculated by adding all
ten scores and diving by 10 (10).
2.2.4. Disease activity
The Turkish version of Bath Ankylosing Spondylitis
Disease Activity Index (BASDAI) was used to measure
patient-reported disease activity. It consists of six questions
related to five symptoms of AS: fatigue, spinal pain, joint
pain and swelling, areas of local tenderness, and morning
stiffness. A 10-cm VAS was used to measure the patient
responses to each question. A score between 0 and 10 was
obtained for each question, and the mean of two questions
relating to morning stiffness was used. The resulting
overall score was converted to a 0–10 scale in which 0 =
good and 10 = bad (8,11).
2.2.5. Kinesiophobia
Kinesiophobia was evaluated using the Turkish version
of the Tampa Scale for Kinesiophobia (TSK). This scale
comprises 17 questions developed in order to measure fear
of movement and/or reinjury. The scale includes injury/
reinjury and fear-avoidance parameters in occupational
activities. The scale uses 4-point Likert scoring (1 = entirely
disagree, 4 = entirely agree). A total score is calculated
after inverting items 4, 8, 12, and 16. The individual
obtains a total score ranging between 17 and 68. Higher
scores show a high kinesiophobia level. A cut-off point of
37 was determined for the scale as ≥37 points indicate a
high kinesiophobia level while <37 points indicate a low
kinesiophobia level (12).
2.2.6. Quality of life
Quality of life was assessed using the Turkish version of
the Ankylosing Spondylitis Quality of Life Questionnaire
(ASQoL). The questionnaire comprises 18 disease-specific
yes/no questions that evaluate the quality of life of patients
with AS. It assesses symptoms, functions, and concerns
about the disease. The answer ‘yes’ is given a score of 1
point and 0 points are given to ‘no’ answers; the total score
ranges between 0 and 18. Higher scores indicate a worse
quality of life (13).
2.2.7. Psychological condition
The Beck Depression Inventory (BDI) is a multiplechoice self-report inventory consisting of 21 specific
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categories. Each item is given a score ranging between 0
and 3. The highest possible score is 63. Higher total scores
indicate more severe depressive symptoms (14).
2.3. Statistical analysis
IBM SPSS 22.0 software was used for statistical analysis.
Student’s t-test was used to compare the kinesiophobia
groups, and Pearson’s correlation test was adopted for
establishing the correlation between parameters. Statistical
significance was accepted as P < 0.05.
3. Results
A total of 163 patients participated in the study. High
levels of kinesiophobia (TSK score of ≥37) were found in
66.6% of patients.
Kinesiophobia was found to be correlated with pain,
BASFI, ASQoL, and BDI scores (P < 0.05) (Figures 1–4),
while no correlation was found with BASMI and BASDAI
scores (P > 0.05) (Table 1).
The patients were classified into 2 groups regarding
their TSK scores. Patients with TSK scores of 37 and
above were classified as the high kinesiophobia group
(Group 1), while those with scores of less than 37 were

classified as the low kinesiophobia group (Group 2). No
differences were found in age and body weight among
the groups (P > 0.05) (Table 2). The BASFI, pain, ASQoL,
and BDI scores and kinesiophobia levels of Group 1 were
found to be higher compared to Group 2 (P < 0.05) (Table
2). However, there was no difference in the high and low
kinesiophobia groups for BASDAI and BASMI scores (P
> 0.05) (Table 2).
4. Discussion
This study is the first to examine the level of kinesiophobia
and its correlation with other clinical variables in patients
with AS. Based on the results of our study, 66.6% of AS
patients had high levels of kinesiophobia. Furthermore,
there was a positive correlation between kinesiophobia and
physical function, pain, and depression levels. However,
kinesiophobia was not correlated with disease activity
or mobility levels. Quality of life and functional levels of
patients with high kinesiophobia were lower as compared
to patients with low kinesiophobia, and their pain and
depression levels were found to be high. However, disease
activity and mobility levels were found to be similar.

Figure 1. The relationship between TSK and pain scores. r: 0.259, P: 0.001; TSK: Tampa Scale for Kinesiophobia.
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Figure 2. The relationship between TSK and BASFI scores. r: 0.294, P < 0.00; TSK: Tampa Scale for
Kinesiophobia; BASFI: Bath AS Functional Index.

Figure 3. The relationship between TSK and ASQoL scores. r: 0.392, P < 0.00; TSK: Tampa Scale for
Kinesiophobia; ASQoL: AS Quality of Life Questionnaire.
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Figure 4. The relationship between TSK and BDI scores. r: 0.398, P < 0.00; TSK: Tampa Scale for
Kinesiophobia; BDI: Beck Depression Inventory.
Table 1. Analysis of the correlation between kinesiophobia and
pain, BASFI, ASQoL, BDI, BASMI, and BASDAI total scores.
TSK score
r

P

Pain

0.259

0.001

BASDAI

0.116

>0.05

BASFI

0.294

<0.001

ASQoL

0.392

<0.001

BDI

0.398

<0.001

BASMI

0.102

>0.05

TSK: Tampa Scale for Kinesiophobia, BASFI: Bath Ankylosing
Spondylitis Functional Index, ASQoL: Ankylosing Spondylitis
Quality of Life Questionnaire, BDI: Beck Depression Index,
BASMI: Bath Ankylosing Spondylitis Metrology Index, BASDAI:
Bath Ankylosing Spondylitis Disease Activity Index.

Most studies on kinesiophobia that were carried out on
chronic musculoskeletal diseases with spinal involvement
revealed a prevalence as high as 50% (15,16). Interestingly,
kinesiophobia in patients suffering from back pain
was higher compared to two other rheumatic disease,

1344

fibromyalgia and osteoarthritis (16). In this study, 66.6%
of AS patients had kinesiophobia, which is much higher
than rates reported for other musculoskeletal disorders.
In this study we found that kinesiophobia in patients
with AS was correlated with pain and depression levels. In
addition, patients with higher levels of kinesiophobia had
significantly higher pain and depression levels compared
to patients with lower levels of kinesiophobia. In previous
studies carried out in different disease groups, a correlation
was put forth between level of pain and kinesiophobia
(17–19). In another study conducted on patients with
rheumatoid arthritis, it was concluded that the feelings of
fear and avoidance of activity had a significant correlation
with pain (20). Parallel to our results, as noted by Leeuwe
et al., fear of pain, fear of movement, and fear of reinjury
were frequently reported in diseases with pain components
such as AS (21). As noted in the definition, kinesiophobia
results and develops from the response to previously
experienced significantly painful movement (22). It is
speculated that the learned fears and pain that AS patients
experience may lead to a further increase in kinesiophobia.
Psychological states observed in relation to chronic
pain generally develop secondary to pain. Chronic pain
accompanies anxiety, insomnia, worry, and, mostly,
depression. Depression increases symptoms and lowers
the pain threshold. It is suggested that patients concentrate
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Table 2. Age, body weight, pain, disease activity, functionality, quality of life, psychological condition, and mobility
levels in low and high kinesiophobia groups
Group 2: low
kinesiophobia (n = 59)

Group 1: high
kinesiophobia (n = 102)

P

Age

38.6 ± 12

37.6 ± 10

ns

Body weight (kg)

70.6 ± 13.2

74.7 ± 13.1

ns

Pain (VAS)

4.73 ± 2.78

5.93 ± 2.82

0.01

BASDAI

1.06 ± 0.75

1.34 ± 0.96

>0.05

BASFI

1.67 ± 1.92

3.08 ± 2.38

<0.001

ASQoL

6.98 ± 4.81

10.76 ± 5.11

<0.001

BDI

8.81 ± 7.07

14.29 ± 9.18

<0.001

BASMI

2.44 ± 1.44

2.71 ± 1.73

>0.05

TSK: Tampa Scale for Kinesiophobia; BASFI: Bath Ankylosing Spondylitis Functional Index, ASQoL: Ankylosing
Spondylitis Quality of Life Questionnaire, BDI: Beck Depression Inventory, BASMI: Bath Ankylosing Spondylitis
Metrology Index, BASDAI : Bath Ankylosing Spondylitis Disease Activity Index, ns: nonsignificant.

on their pain and decrease their concentration on positive
events in their lives and thus alter their perception of pain
(23). Depression is known to contribute to momentary
pain sensitivity or pain sensitivity even after 6–12 months
(17). Depression is a frequently observed symptom in
rheumatologic diseases (24). It has been stated before
that in AS patients who have chronic pain, symptoms of
depression are frequently encountered (25). In a study
conducted by Baysal et al. the correlation between chronic
pain and depression in patients with AS was clearly
demonstrated (26). Moreover, severity of depression was
increased by the severity and duration of pain (27). In
a study conducted on patients with chronic pain, it was
reported that avoidance of activity was also affected by
depression and pain was also correlated with kinesiophobia
(28). We have observed similar associations in our study.
Another significant result of our study is the
association of kinesiophobia and functional status.
Functional limitation in AS was shown to be correlated
with axial and peripheral joint lesions, pain, and soft tissue
inflammation, and thus overall with disease activity (29).
Like kinesiophobia, increase in the severity of disease and
decrease in spinal mobility are also factors affecting physical
activity and function in AS. Thus, what was expected as
a result of our study was kinesiophobia being correlated
with an increase in disease activity and a decrease in the
level of mobility. However, kinesiophobia was correlated
neither with disease activity nor with mobility in our
study, suggesting that kinesiophobia in patients with AS is
a direct result of body pain and depression.

In light of our results, it is still doubtful if these patients
prefer moving despite their high kinesiophobia levels.
This could be assessed ideally by measuring the physical
activity level. However, we could not discuss this state as
it is out of the scope of this study and further studies may
contribute to this topic.
Exercise is the sine qua non of AS treatment (30).
Kinesiophobia is one of the pivotal factors that impair
participation of AS patients in exercise programs.
Therefore, to increase the patients’ compliance to the
exercise programs, strategies must be developed to improve
the factors that induce or worsen kinesiophobia, such as
pain and depression. For this reason, exercises that would
trigger pain during the treatment of patients with AS
should be avoided and patients should be taught methods
of coping with pain. In this regard, exercises suggested
for treatment should not be established through a general
approach but should be specific for each patient. In patients
suffering from pain with a high level of kinesiophobia,
it was acknowledged that patient education centered on
kinesiophobia and activity avoidance decreased the fear
of movement that developed due to pain and also pain
sensitivity, and increased physical activity levels (31,32).
Although experimenting is necessary, we believe that such
types of training programs might contribute to decreasing
kinesiophobia in AS. In addition, it should be considered
that each patient is a biopsychosocial individual. Not only
physical insufficiencies but also the psychological issues
they may be suffering from can reduce the patients’ skills
to cope with the disease and lead to a decrease in voluntary
and active participation in treatment.
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